(Subst Abuse Treat Prev Policy[TA])
1,073 results
  • Smoking cessation experiences during alcohol and cannabis treatment in substance use programmes in Catalonia: A qualitative study. [Journal Article]
    Subst Abuse Treat Prev Policy. 2026 Aug 01; 21(1).Rosa N, Enríquez M, … Martínez CSA
  • CONCLUSIONS: Participants endorsed addressing tobacco cessation in alcohol and cannabis treatment but reported multiple structural, financial, and attitudinal barriers within public substance use services. Systematically integrating tobacco assessment, personalised counselling, and subsidised pharmacological support into these programmes could enhance cessation outcomes and potentially improve recovery outcomes for co-occurring substance use disorders. Findings support policy initiatives aimed at embedding comprehensive tobacco cessation pathways in Spanish addiction services.
  • Initiation, appeal, and dependence: a qualitative exploration of e-cigarette use in Chile. [Journal Article]
    Subst Abuse Treat Prev Policy. 2026 Jul 29; 21(1).Silva-Gallardo C, Astudillo G, … Rocha-Jiménez TSA
  • CONCLUSIONS: E-cigarette use was closely tied to social settings, aesthetic appeal, and daily routines. Product engagement was shaped more by usability and context than by nicotine content or health motivations. These findings highlight the need for policies that address informal sales channels, improve product transparency, and consider the social and sensory drivers of e-cigarette use in underregulated contexts.
  • Treatment interventions for co-occurring opioid use disorder, and sleep disturbances: a scoping review. [Systematic Review]
    Subst Abuse Treat Prev Policy. 2026 Jul 27; 21(1).Ruppert E, Rolling J, … Lalanne LSA
  • CONCLUSIONS: Improved characterization and management of impaired sleep in individuals with OUD and psychiatric symptoms may reduce relapse risk, enhance emotional regulation, and decrease self-medication. Clinicians should consider the complex interplay between OUD, psychiatric symptoms, and sleep as part of comprehensive care. Further research is needed to clarify these interactions and support the development of integrated, evidence-based strategies for treatment and prevention.
  • Assessment of drug harm by final-year medical students and ChatGPT - a comparative analysis. [Journal Article]
    Subst Abuse Treat Prev Policy. 2026 Sep 12; 21(1).Näslund I, Ott M, … Werneke USA
  • CONCLUSIONS: Students and ChatGPT strongly agreed on the most harmful substances but differed in their assessments of moderately and minimally harmful drugs. These differences suggest that perceptions of drug harm are shaped not only by pharmacology and toxicity but also by social and cultural context, local patterns of use, clinical exposure and experience, and medical training. AI may be of limited value when the evidence base is sparse, contested, or difficult to trace. The lower confidence among students suggests that further research is needed to better understand educational needs in drug-harm assessment and the critical appraisal of AI-generated evidence.
  • Unemployment & opioid use disorder - socio-medical assessment results by the Medical Service of the German Federal Employment Agency. [Journal Article]
    Subst Abuse Treat Prev Policy. 2026 Jul 29; 21(1).Soyka M, Manz K, Franke AGSA
  • CONCLUSIONS: The number of unemployed individuals with opioid dependence in Germany has increased over time, and most are unable to work more than three hours per day. The most frequent psychiatric comorbidities were other substance use disorders, particularly alcohol use disorder, schizophrenia, and depression. Somatic comorbidities, with the exception of chronic viral hepatitis, were recorded less frequently. Tailored interventions and closer collaboration between employment agencies and mental health care providers are needed to improve the psychosocial integration of this population.
  • Managing benzodiazepine dependence arising from use of the adulterated opioid supply: a commentary. [Journal Article]
    Subst Abuse Treat Prev Policy. 2026 Jul 20; 21(1).Parmar G, Malette N, … Bach PSA
  • The growing presence of benzodiazepine-adulterated opioids in the unregulated drug supply poses significant challenges for clinicians treating people with opioid use disorder. This commentary highlights key areas of uncertainty and emerging agreement on screening, risk assessment, withdrawal timelines, and treatment approaches for individuals using benzodiazepine-adulterated opioids. It also iden…
  • Is routine screening for substance use disorders useful in palliative care? Results of a prospective observational study. [Journal Article]
    Subst Abuse Treat Prev Policy. 2026 Jul 15; 21(1).Volberg C, Toussaint K, … Heuser NSA
  • CONCLUSIONS: This survey found that routinely screening palliative care patients for substance use disorders did not provide any clinically relevant information for further treatment of the examined cohort. Given the high level of stress often experienced by people with incurable diseases, the extent to which screening is helpful or merely an unnecessary burden should be considered. As other surveys have shown that palliative care patients with substance use disorders benefit from treatment, follow-up studies should investigate how to identify patients at risk specifically.